SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zenotech Lab gets USFDA approval for ondansetron injection

26 Sep 2011 Evaluate

Zenotech Laboratories has received approval from the US Food and Drug Administration (USFDA) for its ondansetron injection, a copy of Glaxosmithkline Plc’s Zofran anti-nausea medicine.

Zenotech develops and manufactures generic bio-pharmaceuticals and markets them to people with unmet medical needs around the world. The company aims to bring a constant pipeline of new biogeneric products to the market. The highly qualified and trained staff uses recombinant DNA technology and cGMP production methods to give the customers generic versions of biotherapeutic drugs comparable to the innovator product in quality, safety and efficacy.

Zenotech Laboratorie Share Price

47.20 0.15 (0.32%)
11-May-2026 12:22 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1874.30
Dr. Reddys Lab 1297.00
Cipla 1317.60
Zydus Lifesciences 944.10
Lupin 2262.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×